← Eichor
Study identifier: NCT06744387 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Anterolateral Tigh (ALT) Flaps Oxygenation Monitoring by NIRS

Condition: Reconstructive Flap Surgery · Fasciocutaneous Anterolateral Thigh Flap · Postoperative Monitoring  ·  Sponsor: University Hospital, Antwerp

PhaseN/A
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to conduct postoperative monitoring in patients who have undergone upper or lower limb reconstructive surgery with an anterolateral thigh flap, by employing the gold standard approach: intermittent assessment of clinical parameters (flap's color, temperature, skin turgor and capillary refill time) combined with Doppler techniques, alongside continuous tissue oxygenation measurements obtained using the CASMED FORE-SIGHT ELITE monitor.The main objective of the study is to provide preliminary data on potential cut-off values indicative of flap failure.

This description comes directly from the study's public registry record.

Talk to the study team

Vera Saldien, MD  ·  38214788  ·  vera.saldien@uza.be

Always discuss trial participation with your own doctor first.

Locations (1)

Antwerp University HospitalEdegem, Antwerp, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06744387